Camurus AB (publ) (CAMRF) Financials
CAMRF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 516.2 million | 55.8 million |
| Dec. 31, 2025 | 514.8 million | 54.8 million |
| Sept. 30, 2025 | 487.9 million | 53.8 million |
| June 30, 2025 | 468.0 million | 58.6 million |
CAMRF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 12.8 million | ? |
| Dec. 31, 2025 | 22.8 million | -1.7 million |
| Sept. 30, 2025 | 13.7 million | ? |
| June 30, 2025 | 36.9 million | 2.9 million |
CAMRF Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2026 | 15.0 million |
| Dec. 31, 2025 | 12.2 million |
| Sept. 30, 2025 | 20.3 million |
| June 30, 2025 | 30.9 million |
CAMRF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 403.5 million | - | 9.2 million |
| Dec. 31, 2025 | 404.7 million | - | 11.5 million |
| Sept. 30, 2025 | 370.6 million | 9.1 million | 9.1 million |
| June 30, 2025 | 354.1 million | - | 11.0 million |
CAMRF Shares Outstanding
CAMRF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 4.1 million | 13.6 million | 18.5 million | - |
| Dec. 31, 2025 | 5.0 million | 13.6 million | 20.0 million | 14.9 million |
| Sept. 30, 2025 | 3.2 million | 10.9 million | 19.1 million | - |
| June 30, 2025 | 2.9 million | 16.0 million | 19.6 million | 14.1 million |
CAMRF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 55.5 million | 4.6 million |
| Dec. 31, 2025 | 50.4 million | 4.0 million |
| Sept. 30, 2025 | 59.8 million | 4.8 million |
| June 30, 2025 | 71.5 million | 4.4 million |
CAMRF
Price: $54.95
52 week price:
Earnings Per Share: 1.21 USD
P/E Ratio: 52.31
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.6 billion